Science to Consumers, Inc. (S2C) is focused on anti-aging and good-for-your-body products.
Utilizing 21st century science and cost-effective high-return marketing, the company is poised to take advantage of the aging of the largest single demographic group in history – baby boomers.
The first product the company plans to sell is Dermalastyl skin care products. DermaLastyl is a trademarked anti-aging cream that helps to reduce wrinkles through the use of revolutionary science.
The key ingredient, Tropoelastin, is a patented formulation of elastin produced by genetic engineering that promotes healing and renewing of the skin.
Protein Genomics, Inc., based in Flagstaff, Arizona, created Tropoelastin specifically to heal wounds. S2C has the exclusive license and rights to market Tropoelastin for cosmetic applications in China and Europe.
The anti-aging skin care market is exploding, with current sales of $5 billion in the US alone.
The patented science and IP technology licensed to S2C provides an advantage over the competition.
Elastin, along with collagen, is an important component to healthy, youthful skin. Elastin helps skin maintain its elasticity. As we age, both elastin and collagen levels decrease, and hence the skin itself loses its firm appearance.
Many products and treatments have been introduced in recent years designed to increase collagen levels, yet elastin replacement has been elusive.
DermaLastyl has been created through genetic engineering as a source of elastin and has been shown to repair and heal damaged elastin, helping to reverse the appearance of wrinkles and returning skin to its youthful appearance.
Product launch: the company has three channels of distribution planned. The majority of offering proceeds will be allocated to advertising centered on a direct-to-consumer model. S2C intends to utilize its online presence with a low cost-high return media buy campaign.
Protein Genomics Inc also has a fully developed product pipeline, with a hair growth product in the market and an eyelash / eyebrow growth product in clinical testing with promising results.
DermaLastyl is truly a new-age cosmetic. It was created by Dr. Burt Ensley, a pioneer in genetic engineering. With manufacture of the product carried out by accredited vendors, an existing e-commerce site accepting credit cards and fulfillment centers currently distributing product, S2C is poised to begin to capture significant sales with a carefully calibrated marketing effort.